Vesicle-Cloaked Virus Clusters as Emerging Pathogens: Will They Challenge Current Disinfection Paradigm?
囊泡包裹的病毒簇作为新兴病原体:它们会挑战当前的消毒范式吗?
基本信息
- 批准号:10373373
- 负责人:
- 金额:$ 22.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-23 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAntiviral AgentsAttentionBenchmarkingBindingBiologicalBiomedical ResearchCapsidCationsCell Culture TechniquesCellsCessation of lifeChloridesCommunicable DiseasesCoronavirusCoxsackie VirusesDeveloping CountriesDiarrheaDisease OutbreaksDisinfectantsDisinfectionDoseEthanolFecesFoodGastroenteritisGenomeHarvestHealthHepatitis AHepatitis E virusHospital CostsHumanHuman poliovirusHygieneIn VitroIndividualInfectionInfection preventionInternationalInterruptionKineticsLeadLightLipidsMedical Care CostsMembraneMembrane LipidsMurine hepatitis virusMusNorovirusOutcomes ResearchOxidesPerformancePersonsProcessProteinsPublic HealthReactionRhinovirusRotavirusSurfaceTranslatingUltraviolet RaysVaccinationVaccinesVesicleViralVirusWaterWorkcostdesigndosageemerging pathogenextracellular vesiclesfood sanitationoperationparticlepathogenpreventresponsesurfactanttransmission processultraviolet irradiationvirus envelope
项目摘要
Project Summary/Abstract
Rotavirus and norovirus are well-known to lead to serious gastroenteritis in humans and great public health
concerns. Both viruses are environmentally persistent, and they can be transmitted via direct contact with an
infected person or contaminated surfaces, as well as polluted water and food. Disinfection can inactivate these
persistent viruses and prevent infectious disease outbreaks. Almost all previous studies consider rotavirus and
norovirus as individual, free viral particles in biomedical research, until a recent finding demonstrated that
rotavirus and norovirus could transmit in vitro as viral clusters inside extracellular vesicles that have a lipid-rich
membrane structure, i.e., vesicle-cloaked virus clusters (viral vesicles for simplicity). Vesicle-cloaked rotavirus
and norovirus clusters are important emerging pathogens, because they are environmentally stable, widely
present, and more infectious than their free viral particle counterpart; however, their inactivation by current
disinfection strategies is unknown. Moreover, disinfection mechanisms are largely unclear, which prevents us
from rational design of effective, robust, broad-spectrum, and low-cost disinfection processes. This project seeks
to evaluate the performance of conventional disinfection strategies for inactivating vesicle-cloaked rotavirus and
norovirus clusters, elucidate the mechanisms of viral vesicle inactivation, and develop new disinfection
processes for effective viral vesicle inactivation. Our central hypothesis is that the vesicle-cloaked virus clusters
are more persistent in disinfection compared to their counterpart of free viruses, and disinfection that damages
multiple biological components in viral vesicles is more effective. Specific Aim 1 will evaluate the inactivation of
vesicle-cloaked virus clusters by conventional disinfectants, i.e., bleach, ultraviolet light (monochromatic UV 254
nm), a surfactant (didecyldimethylammonium chloride), ethanol, and their combination. The dosage of
disinfectants and their performance in disinfection will be determined to generate a dose-response relationship,
which will be compared with that for free viruses. Specific Aim 2 will elucidate the mechanisms of inactivating
vesicle-cloaked virus clusters by conventional disinfectants to understand the key factor that determines
disinfection performance. The damage of biological components of viral vesicles and the impact on viral vesicles’
lifecycle in the host cells after disinfection will be evaluated. Specific Aim 3 will evaluate emerging disinfectants,
i.e., polychromatic UV irradiation and activated persulfate, for inactivating vesicle-cloaked virus clusters. Both
disinfection performance and mechanisms will be explored. Our study will shed light on the need for optimizing
current disinfection paradigm and developing new disinfection strategies for rotavirus and norovirus, and it has
a broader health impact because research outcomes can be translated into inactivating other related viruses
(e.g., poliovirus, coxsackievirus, rhinovirus, hepatitis A and E viruses), which are environmentally persistent and
could also form vesicle-cloaked virus clusters.
项目总结/摘要
众所周知,轮状病毒和诺如病毒会导致人类严重的胃肠炎,并极大地影响公共卫生
性问题这两种病毒都具有环境持久性,它们可以通过直接接触传播。
受感染的人或受污染的表面,以及受污染的水和食物。消毒可以消除这些
持久性病毒和预防传染病爆发。几乎所有以前的研究都认为轮状病毒和
在生物医学研究中,诺如病毒作为单独的、游离的病毒颗粒,直到最近的一项发现表明,
轮状病毒和诺如病毒可以在体外作为病毒簇在细胞外囊泡内传播,
膜结构,即,囊泡包被的病毒簇(简单来说是病毒囊泡)。囊泡包被轮状病毒
诺如病毒簇是重要的新兴病原体,因为它们在环境中稳定,
存在,并且比它们的游离病毒颗粒对应物更具感染性;然而,它们被电流灭活,
消毒策略尚不清楚。此外,消毒机制在很大程度上还不清楚,这使我们无法
从有效的,强大的,广谱的,低成本的消毒过程的合理设计。项目的目标是
评价灭活囊泡包被轮状病毒的常规消毒策略的性能,
诺如病毒簇,阐明病毒囊泡灭活机制,并开发新的消毒剂
用于有效的病毒囊泡灭活的方法。我们的核心假设是囊泡病毒聚集在
与游离病毒的对应物相比,
病毒囊泡中的多种生物成分更有效。具体目标1将评价以下物质的灭活
常规消毒剂,即,漂白剂,紫外光(单色UV 254
nm)、表面活性剂(二癸基二甲基氯化铵)、乙醇和它们的组合。的剂量
将确定消毒剂及其消毒性能以产生剂量-反应关系,
这将与自由病毒的情况进行比较。具体目标2将阐明失活的机制
泡状病毒群,以了解决定
消毒性能病毒囊泡生物组分的损伤及其对病毒囊泡寿命的影响
将评价消毒后宿主细胞中的生命周期。具体目标3将评估新兴的消毒剂,
也就是说,多色紫外线照射和活化过硫酸盐,用于灭活囊泡包裹的病毒簇。两
消毒性能和机制将被探索。我们的研究将阐明优化的必要性
目前的消毒模式和开发新的消毒策略轮状病毒和诺如病毒,它已经
更广泛的健康影响,因为研究成果可以转化为灭活其他相关病毒
(e.g.,脊髓灰质炎病毒、柯萨奇病毒、鼻病毒、甲型和戊型肝炎病毒),这些病毒具有环境持久性,
也能形成囊泡状病毒簇。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yun Shen其他文献
Yun Shen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yun Shen', 18)}}的其他基金
Vesicle-Cloaked Virus Clusters as Emerging Pathogens: Will They Challenge Current Disinfection Paradigm?
囊泡包裹的病毒簇作为新兴病原体:它们会挑战当前的消毒范式吗?
- 批准号:
10494266 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 22.47万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 22.47万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 22.47万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 22.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 22.47万 - 项目类别: